Yorkshire Building Society Publication of Prospectus Supplement (4816A)

TIDMYBSC

RNS Number : 4816A

Yorkshire Building Society

23 September 2022

Publication of Supplement to Base Prospectus

The following supplement to a base prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplement dated 23 September 2022 to the Base Prospectus dated 1 April 2022 (the "Base Prospectus") in connection with the GBP5,000,000,000 Note Programme of Yorkshire Building Society.

To view the supplement and the document incorporated by reference, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4816A_1-2022-9-23.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4816A_2-2022-9-23.pdf

For further information, please contact:

Yorkshire Building Society

Yorkshire House

Yorkshire Drive

Bradford, West Yorkshire

BD5 8LJ

   Telephone:       [phone] 
   Email:               [e-mail] 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus (as supplemented) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus, you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, the Base Prospectus does not constitute an offer of securities for sale in the United States. This is not for distribution in the United States. The securities described therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PSPLJMMTMTBTBBT

(END) Dow Jones Newswires

September 23, 2022 06:16 ET (10:16 GMT)